← FDA Drug Approvals (Drugs@FDA)
ABACAVIR SULFATE AND LAMIVUDINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LAURUS · Approved 2022-07-25
Drug application
- FDA Application #
ANDA216332- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ABACAVIR SULFATE AND LAMIVUDINE
- Generic name
- ABACAVIR AND LAMIVUDINE
- Active ingredients
- ABACAVIR SULFATE; LAMIVUDINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- LAURUS
- Manufacturer
- Laurus Labs Limited
- First approval
- 2022-07-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown